Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 22,900
-250 (-1.08%)
At close: Apr 29, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 333.92 billion as of April 30, 2026. Its market cap has increased by 279.64% in one year.
Market Cap
333.92B
Enterprise Value
304.40B
Revenue
2.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
22,900.00
Market Cap Chart
Since December 5, 2023, Y-Biologics's market cap has increased from 177.50B to 333.92B, an increase of 88.13%. That is a compound annual growth rate of 30.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 347.58B | - |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IntoCell | 580.60B |
| Kanaph Therapeutics | 504.08B |
| S.Biomedics | 456.39B |
| HansBiomed | 419.28B |
| curacle co.,ltd. | 389.44B |
| Kangstem Biotech | 379.98B |
| TiumBio | 361.10B |
| NIBEC | 306.36B |